BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

SK Bioscience Wins Patent Case Against Moderna Clearing Path for Global mRNA Vaccine Development

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has won...

April 24, 2025 | News

Docquity and AstraZeneca Strengthen Cancer and RSV Vaccine Support in Southeast Asia Through OAZisCare

OAZisCare, digitally powered by DocquityCare, has advanced patient education and adherence for cancer care and RSV vaccines since 2024 The collaboration...

April 23, 2025 | News

Singapore’s T Cell Diagnostics Licenses Duke-NUS Technology to Develop Rapid Point-of-Care T-Cell Assays

T Cell Diagnostics Pte. Ltd. ("TCD") has licensed an intellectual property (IP) and its related know-how from Duke-NUS Medical School to develop point-of-c...

April 18, 2025 | News

Thermo Fisher Launches 5L DynaDrive Single-Use Bioreactor to Accelerate Scalable Bioprocessing

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the 5L DynaDrive™ Single-Use Bioreactor (S.U.B.), designed to meet...

April 15, 2025 | News

GC Biopharma and KDCA Secure MFDS Approval for Korea’s First Recombinant Anthrax Vaccine, BARYTHRAX

GC Biopharma announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly developed by...

April 10, 2025 | News

China’s AIM Vaccine Set to Launch World’s First Serum-Free Rabies Vaccine Following Regulatory Acceptance

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced on April 7, 2025 that the company's research and development of the se...

April 08, 2025 | News

RNA Therapeutics 2024: From Pandemic Pivots to Precision Powerhouses

2024 marked a transformative year for RNA therapeutics. What began as a pandemic-driven innovation sprint has evolved into a diversified, multi-platform fr...

April 03, 2025 | Analysis

Vaximm Reports Promising Final Data from Phase 2a Trial of Oral Vaccine VXM01 with Avelumab in Recurrent Glioblastoma

Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies, announced fina...

March 27, 2025 | News

China’s Everest Gets FDA Clearance for First mRNA Cancer Vaccine EVM14

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer ...

March 25, 2025 | News

China’s AIM Vaccine Gets FDA Nod for mRNA Shingles Vaccine Trial

AIM Vaccine Co., developed mRNA shingles vaccine has recently received clinical trial approval from the U.S. Food and Drug Administration (FDA). As o...

March 25, 2025 | News

SK bioscience Ships 750,000 Influenza Vaccine Doses to Southeast Asia and Latin America

750,000 doses of influenza vaccine to be supplied to Southeast Asia and Latin America in the first half of the year. Expanded exports markets ensure yea...

March 12, 2025 | News

AIM Vaccine Secures Production License for World’s First Serum-Free Rabies Vaccine

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 12, 2025, the company's serum-free iterative rabie...

March 12, 2025 | News

NEC Partners with Nagasaki University and CEPI to Advance AI-Driven mRNA Vaccine for SFTS and Future Epidemic Threats

NEC Partners with Nagasaki University and CEPI to Develop AI-Driven mRNA Vaccine for SFTS and Future Epidemic Threats NEC Corporation (NEC; TSE: 6701) has...

March 10, 2025 | News

AIM Vaccine Secures Clinical Approval for Next-Gen Diploid Rabies Vaccine, Marking a Major Technological Leap

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025, the company's research and development of...

March 10, 2025 | News

Stay Connected